The Shipment Arrived. The Inventory Didn't: Understanding The Hidden Data Dependencies Behind Depot-To-Site Deliveries
By Priyanko Ghosh
A site receives a shipment on Tuesday morning. The pharmacist confirms the cartons are intact. Temperature monitors show acceptable transit conditions. Physically, the product is available.
On Wednesday, the IRT still shows insufficient inventory at the site. By Thursday, an emergency resupply request is generated. By Friday, the study team is investigating what appears to be a supply planning issue.
The shipment was not late. The depot did not make a mistake. The site did not lose inventory. The problem was a missing data transition.
Many times people have found that many depot-to-site issues are not caused by product movement. They are caused by assumptions about how information moves between systems. The physical shipment is usually the easy part. The difficult part is ensuring that every inventory-related event arrives in the correct sequence and at the correct time.
A Depot-To-Site Shipment Is Really A Series Of Inventory State Changes
Clinical supply teams often view shipments through a logistics lens: Pick, Pack, Ship, Receive. Systems do not.
Most supply ecosystems see a shipment as a sequence of inventory state transitions. Product moves through statuses such as Available, Assigned, In Transit, Received, Quarantined, or Released. Each transition depends on a specific transaction occurring in the expected order.
A typical shipment may involve:
- inventory allocation
- shipment creation
- dispatch confirmation
- site receipt confirmation
- temperature review
- inventory release for dispensing.
The important detail is that these events do not occur simultaneously. They are often processed by different functions, different systems, and different timelines. As a result, physical reality and system reality can temporarily diverge.
A site may physically possess inventory that the system still considers in transit. Conversely, planning teams may assume inventory is available because delivery occurred while quality review still prevents use. Most reconciliation activities begin when those two realities fail to converge as expected.
The Decision Rule Most Teams Underestimate
One system’s behavior consistently creates confusion: inventory is not available simply because it exists at the site. Inventory becomes available only after the event defined by the study's traceability and inventory control rules. That sounds obvious, but teams frequently operate with different assumptions.
A pharmacist may consider inventory available once the shipment arrives. A supply planner may consider it available after receipt confirmation. Quality may require temperature review before release. The IRT may wait for a specific transaction before including that stock in allocation calculations.
The result is a critical dependency chain:
Shipment Received → Receipt Confirmed → Inventory Updated → Inventory Eligible for Assignment
If any step is delayed, downstream calculations may produce unexpected results. There are times when enrollment forecasts are questioned, depot stock levels challenged, and resupply algorithms blamed when the actual issue was a delayed receipt confirmation. The planning logic was functioning exactly as designed. It was operating on inventory that had not yet transitioned into an allocatable state.
This distinction becomes particularly important during enrollment spikes when even a short delay in inventory visibility can trigger unnecessary resupply activity.
Why Global Studies Amplify the Problem
Global trials expose data dependencies that are often invisible in regional studies. Consider two sites receiving identical shipments. The first site confirms receipts within two hours of delivery. The second confirms receipt the following day because local procedures require inventory review before system updates occur. Physically, both sites received products at nearly the same time. Operationally, they entered different inventory states.
From the perspective of central supply planning, that difference can affect:
- site inventory visibility
- automatic resupply triggers
- depot demand forecasting
- expiry-risk calculations
- traceability reconciliation.
The same challenge appears across depot networks. One regional operation may transmit shipment transactions in near real time, while another relies on scheduled updates. Both processes can be compliant, yet they generate different inventory visibility profiles. What appears to be a supply issue frequently turns out to be a timing issue.
This is why experienced clinical supply teams investigate transaction timelines alongside shipment timelines. Knowing when the truck moved is important. Knowing when the inventory state changes is often more important.
Practitioner Takeaways:
- Map inventory-state transitions during study start-up. Ask a simple question: Exactly which event makes inventory eligible for patient assignment? If supply, quality, and site operations provide different answers, a future exception is already waiting to happen.
- Investigate sequencing, not just execution. When inventory discrepancies or unexpected resupply requests occur, reconstruct the timing of dispatch, receipt, quality review, and inventory release transactions. In many cases, every process is executed correctly, but not in the sequence the downstream systems expected.
Depot-to-site shipments are often described as logistics activities. In practice, they are synchronized data events wrapped around product movement. The teams that understand those hidden dependencies spend far less time reconciling inventory exceptions and far more time ensuring product is available when patients need it.
About The Author:
Priyanko Ghosh is an accomplished Life Sciences professional with expertise spanning Clinical R&D and Pharmaceutical Supply Chain operations. He is dedicated on driving end-to-end operational efficiency, regulatory compliance, and cross-functional innovation to streamline global product life cycles. Priyanko’s work focuses on resilient supply networks that accelerate the delivery of therapies to patients worldwide.
He is passionate about transforming clinical and pharmaceutical operations. Priyanko is excited to engage with the Clinical Supply Leader community to exchange insights, address industry challenges, and explore innovative approaches that will shape the future of clinical logistics and healthcare delivery.